Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 1/20 | 0.70 |
| ▸ | TERT | O14746 | 5/20 | 0.67 |
| ▸ | TOP1 | P11387 | 4/20 | 0.56 |
| ▸ | CYCS | P99999 | 3/20 | 0.55 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30205815 | 0.97 | ENPP2 (0.70) | ENPP2TERTTOP1CYCSABCG2 | |
| SCHEMBL2334489 | 0.97 | ENPP2 (0.70) | ENPP2TERTTOP1CYCSABCG2 | |
| SCHEMBL2334465 | 0.97 | ENPP2 (0.70) | ENPP2TERTTOP1CYCSABCG2 | |
| SCHEMBL498417 | 0.97 | ENPP2 (0.70) | ENPP2TERTTOP1CYCSABCG2 | |
| SCHEMBL6139711 | 0.97 | ENPP2 (0.70) | ENPP2TERTTOP1CYCSABCG2 | |
| SCHEMBL23706379 | 0.97 | ENPP2 (0.70) | ENPP2TERTTOP1CYCSABCG2 | |
| Zinc Ion SCHEMBL11569891 | 0.97 | ENPP2 (0.70) | ENPP2TERTTOP1CYCSABCG2 | |
| SCHEMBL9267975 | 0.97 | TERT (0.71) | ENPP2TERTTOP1CYCSABCG2 | |
| SCHEMBL8994427 | 0.97 | ENPP2 (0.70) | ENPP2TERTTOP1CYCSABCG2 | |
| SCHEMBL3942334 | 0.97 | ENPP2 (0.70) | ENPP2TERTTOP1CYCSABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9597419-B2 | Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same | BOSTON SCIENTIFIC LIMITED (BM) | 2017-03-21 | — | — | US | claimed |
| US-20150258224-A1 | LOADABLE POLYMERIC PARTICLES FOR ENHANCED IMAGING IN CLINICAL APPLICATIONS AND METHODS OF PREPARING AND USING THE SAME | VARIAN MEDICAL SYSTEMS, INC. | 2015-09-17 | — | — | US | claimed |
| US-9114162-B2 | Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same | CELONOVA BIOSCIENCES, INC. (US) | 2015-08-25 | — | — | US | claimed |
| US-20080102029-A1 | Loadable Polymeric Particles For Enhanced Imaging In Clinical Applications And Methods Of Preparing And Using The Same | CELONOVA BIOSCIENCES, INC. (US) | 2008-05-01 | — | — | US | claimed |
| WO-2023068193-A1 | DETOXIFYING AGENT, DETOXIFYING AGENT KIT, AND NOVEL INCLUSION COMPLEX | 学校法人同志社 | 2023-04-27 | — | — | WO | disclosed |
| WO-2021153197-A1 | CARBON MONOXIDE QUANTIFICATION METHOD AND CARBON MONOXIDE MEASUREMENT KIT | 学校法人同志社 | 2021-08-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150258224-A1 | LOADABLE POLYMERIC PARTICLES FOR ENHANCED IMAGING IN CLINICAL APPLICATIONS AND METHODS OF PREPARING AND USING THE SAME | PHOSPHO1, FGB, HPSE | ENPP2 1150/4885TERT 1590/4885TOP1 473/4885 |
| US-20080102029-A1 | Loadable Polymeric Particles For Enhanced Imaging In Clinical Applications And Methods Of Preparing And Using The Same | PHOSPHO1, FGB, HPSE | ENPP2 1150/4885TERT 1590/4885TOP1 473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.